Dendritic Cell-Based Immunotherapy in Patients with Resected Pancreatic Cancer: A Promising Strategy for Preventing Recurrence
Discover the promising potential of dendritic cell-based immunotherapy for preventing recurrence in patients with resected pancreatic cancer. A groundbreaking phase I/II clinical trial demonstrates that this immunotherapy approach significantly improves
Dawn, une patiente atteinte d'un cancer du rein, partage son parcours et l'impact de la thérapie lors du symposium international sur le cancer du rein, soulignant l'importance de prendre le
The Future of Cancer Therapy: Innovations in Immunotherapy
Bladder cancer is a type of cancer that starts in the cells of the bladder, the organ in the pelvis that stores urine. In the face of this challenge, medical
